Previous close | 193.70 |
Open | 192.75 |
Bid | 245.35 |
Ask | 253.40 |
Strike | 380.00 |
Expiry date | 2025-12-19 |
Day's range | 192.75 - 193.70 |
Contract range | N/A |
Volume | |
Open interest | 11 |
These 5 stocks are red hot and hitting new all-time highs. Have you missed the trade?
Following the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic control in patients aged 10 years and older with T2D. It was previously approved for such use in adults.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.